http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102716112-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b27b13d0dbe6d0bcbbd697ec8df9a5f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-02 |
| filingDate | 2012-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_552f45bb48a0d0e5188fa2a6d2da1d33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc506603a7ce73a8a7b7a97db3be56ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2936cae03611104398a94643c80b2058 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91bda1360fb7b986b64a2c4ba81246f9 |
| publicationDate | 2014-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102716112-B |
| titleOfInvention | Pharmaceutical composition capable of resisting HPV (human papillomavirus) infection |
| abstract | The invention belongs to the technical field of medicines and provides a pharmaceutical composition capable of resisting HPV (human papillomavirus) infection. The pharmaceutical composition capable of resisting HPV infection comprises germacrone, furanodiene, curdione, beta-elemene, curcumol, curzerene and borneol. The components of the pharmaceutical composition are definite, and the quality can be controlled. The weight part of the curzerene is controlled, thus the irritation of the medicine is reduced. The pharmaceutical composition can be used for preparing suppositories, ointments, capsules, effervescent tablets, gels, lotions and film or foam agents. The pharmaceutical composition has a good effect of treating HR-HPV (high risk human papillomavirus) and/or LR-HPV (low risk human papillomavirus) infection and other diseases and can be used widely clinically. |
| priorityDate | 2012-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 147.